John Kelly

John Kelly

Directeur des opérations chez PRECISION BIOSCIENCES, INC.

Fortune : 879 922 $ au 31/07/2026

59 ans
Health Technology
Consumer Services
Health Services

Profil

John Alexander Kelly is currently Director at California Biomedical Innovation Alliance since 2016 and Chief Operating Officer at Precision BioSciences, Inc. starting in 2026.
Former positions include Director-Investor Relations at Pharmacia & Upjohn, Inc., Executive Director-Investor Relations at Novartis Corp.
from 2003 to 2004, Senior Director-Investor Relations at Pharmacia Corp.
from 2002 to 2003, Director at HealthCare Institute of New Jersey, Treasurer & Director at California Life Sciences Association, Vice President-Investor Relations at Bausch & Lomb, Inc. in 2013, Chief Communications Officer & Senior VP-IR at Forest Laboratories, Inc. from 2013 to 2014, Senior Vice President-Investor Relations at Merck & Co., Inc. from 2004 to 2013, Vice President-Investor Relations at Schering-Plough Corp.
USA, Pharmaceutical Sales Representative at The Upjohn Co., Chief Integration Officer & Senior Vice President at Actavis, Inc. from 2014 to 2015, Chief Communications Officer & Executive VP at Allergan UC from 2015 to 2020, and President at Allergan Foundation.
Education includes undergraduate studies at Purdue University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/06/2026 125 883 ( 0,52% ) 879 922 $ 31/07/2026

Postes actifs de John Kelly

SociétésPosteDébut
PRECISION BIOSCIENCES, INC. Directeur des opérations 01/08/2026
Directeur/Membre du Conseil 02/08/2016

Anciens postes connus de John Kelly

SociétésPosteFin
ALLERGAN PLC Public Communications Contact 08/05/2020
Corporate Officer/Principal 01/05/2015
FOREST LABORATORIES, INC. Investor Relations Contact 01/07/2014
Investor Relations Contact 01/08/2013
MERCK & CO., INC. Investor Relations Contact 01/05/2013
Voir l'expérience en détail de John Kelly

Formation de John Kelly

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

75

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. John Kelly